Anti-TNF therapy in the treatment of systemic autoinflammatory diseases: the responses of innate immune cells

先天免疫系统 肿瘤坏死因子α 免疫学 免疫系统 生物
作者
Shuyi Wang,Ruoxi Xiao,Yibo Chen,Yishan Ye,Tianzhen He,Yang Yang,Xin Chen,Chon‐Kit Chou
出处
期刊:Journal of Leukocyte Biology [Oxford University Press]
卷期号:117 (5)
标识
DOI:10.1093/jleuko/qiaf026
摘要

Abstract Systemic autoinflammatory diseases are rare conditions resulting from dysregulation of the innate immune system, culminating in repetitive bouts of systemic inflammation without the presence of external or self-antigens. Most systemic autoinflammatory diseases are associated with mutations in genes affecting the innate immune response. Tumor necrosis factor is a central player in the pathogenesis of numerous chronic inflammatory disorders, and anti-tumor necrosis factor therapy is widely used in the clinical management of systemic autoinflammatory diseases. Tumor necrosis factor inhibitors block the interaction of tumor necrosis factor with its 2 receptors, tumor necrosis factor receptor 1 and tumor necrosis factor receptor 2. These inhibitors primarily target soluble tumor necrosis factor, which mainly binds to tumor necrosis factor receptor 1, exerting anti-inflammatory effects. Interestingly, tumor necrosis factor inhibitors also affect transmembrane tumor necrosis factor, which engages tumor necrosis factor receptor 2 to initiate reverse signaling. This reverse signaling can activate innate immune cells, prevent apoptosis, or paradoxically inhibit the production of pro-inflammatory cytokines. Tumor necrosis factor inhibitors also promote the release of soluble tumor necrosis factor receptor 2, which neutralizes circulating tumor necrosis factor. Some agents targeting tumor necrosis factor receptor 2 can even act as agonists, triggering reverse signaling by binding to transmembrane tumor necrosis factor. While effective, prolonged use of tumor necrosis factor inhibitors may cause significant side effects due to the widespread expression and pleiotropic functions of tumor necrosis factor receptors. A more thorough understanding of the mechanisms underlying the action of tumor necrosis factor inhibitors is required to develop a more effective and safer treatment for systemic autoinflammatory diseases. This article reviews current studies on the role of the innate immune system in systemic autoinflammatory disease pathogenesis, the impact of anti-tumor necrosis factor therapy on innate immune cells, and perspectives on developing improved agents targeting tumor necrosis factor or its receptors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
gao123发布了新的文献求助10
1秒前
Chain发布了新的文献求助10
1秒前
艾格的应助被奋斗断秋采纳,获得10
1秒前
tx的应助被suyuanxian采纳,获得28
1秒前
2秒前
Maestro_S的应助被科研通管家采纳,获得10
4秒前
小马甲的应助被科研通管家采纳,获得10
4秒前
豆豆完成签到 ,获得积分10
4秒前
4秒前
CipherSage的应助被科研通管家采纳,获得10
4秒前
orixero的应助被科研通管家采纳,获得10
4秒前
田様的应助被科研通管家采纳,获得10
5秒前
wanci的应助被科研通管家采纳,获得20
5秒前
5秒前
syvshc的应助被科研通管家采纳,获得10
5秒前
在水一方的应助被科研通管家采纳,获得10
5秒前
5秒前
5秒前
Nole的应助被科研通管家采纳,获得10
5秒前
李健的应助被科研通管家采纳,获得10
5秒前
啥啥啥的应助被科研通管家采纳,获得20
6秒前
6秒前
Lighters完成签到 ,获得积分10
6秒前
Nole的应助被科研通管家采纳,获得10
6秒前
Jasper的应助被Tomsen采纳,获得10
6秒前
6秒前
传奇3的应助被科研通管家采纳,获得10
6秒前
小蘑菇的应助被科研通管家采纳,获得10
6秒前
syvshc的应助被科研通管家采纳,获得10
6秒前
情怀的应助被日桉采纳,获得10
6秒前
7秒前
生动大白菜真实的钥匙完成签到 ,获得积分10
8秒前
苹果芷天发布了新的文献求助10
8秒前
9秒前
科研通AI6.2的应助被喬老師采纳,获得30
9秒前
小貉发布了新的文献求助30
9秒前
moxinyi发布了新的文献求助10
10秒前
NGNL_Kirito完成签到,获得积分10
10秒前
DHVZA发布了新的文献求助10
10秒前
taotaowulongcha完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188563
求助须知:如何正确求助?哪些是违规求助? 9576328
关于积分的说明 21846521
捐赠科研通 7786563
什么是DOI,文献DOI怎么找? 3435354
关于科研通互助平台的介绍 2559627
邀请新用户注册赠送积分活动 2482336